NUP153 is aberrantly expressed in various cancers, including CRC (Wu et al. 2019), HCC (Gan et al. 2022), BC (Zhou and Panté 2010), PCa (Re et al. 2018), and thyroid cancer (Ma et al. 2021). Here, NUP153 is linked to hepatocellular carcinoma.